James Mulay - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
James Mulay has filed 3 SEC Form 4 filings across 1 company in the last 90 days - selling. Lifetime open-market sales: $6.28M.
Profile
James Mulay is a corporate insider at CG Oncology, Inc. (CGON). Mulay has reported 11 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- CG Oncology, Inc.
Trading Pattern
InsiderAlpha's records for James Mulay go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. 27 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role James Mulay has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at CG Oncology, Inc. (CGON) - 10 filings, 2024 to 2026
- Insider at CG Oncology, Inc. (CGON) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 24.2K | $75.16 | $1.82M |
| 2026-07-14 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 24.2K | $26.63 | $644K |
| 2026-06-16 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 1.3K | $60.12 | $79K |
| 2026-06-16 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 1.3K | $12.59 | $16K |
| 2026-06-16 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 654 | $60.12 | $39K |
| 2026-06-16 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 654 | $3.72 | $2K |
| 2026-04-20 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 15.6K | $73.01 | $1.14M |
| 2026-04-20 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 15.6K | $36.63 | $571K |
| 2026-03-17 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 1.3K | $63.50 | $83K |
| 2026-03-17 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 1.3K | $12.59 | $16K |
| 2026-03-17 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 654 | $63.50 | $42K |
| 2026-03-17 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 654 | $3.72 | $2K |
| 2026-01-13 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 10.5K | $52.99 | $556K |
| 2026-01-13 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 10.5K | $12.59 | $132K |
| 2026-01-13 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 654 | $44.16 | $29K |
| 2026-01-13 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 654 | $3.72 | $2K |
| 2025-10-09 | CGON | CG Oncology, Inc. | S - Open-market sale [10b5-1] | 5.9K | $43.99 | $260K |
| 2025-10-09 | CGON | CG Oncology, Inc. | M - Option exercise [10b5-1] | 5.9K | $3.72 | $22K |
| 2025-09-29 | CGON | CG Oncology, Inc. | S - Open-market sale | 12.8K | $39.19 | $500K |
| 2025-09-29 | CGON | CG Oncology, Inc. | M - Option exercise | 12.8K | $1.82 | $23K |
Companies - Last 90 Days
- CG Oncology, Inc. (CGON) - 3 filings, last 2026-07-14
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies James Mulay has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Brian Guan-Chyun Liu - $74.81M of CGON open-market activity in the last 12 months
- Hong Fang Song - $2.78M of CGON open-market activity in the last 12 months
- Leonard E. Post - $1.15M of CGON open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- JANA Partners Management, LP
- Arun Jeldi
- Jan Philipp Jenisch
- Marc Johnson
- James Jones
- Andrew T. Kaplan
- A. J. Kazimi
- Michael John Kazley
Frequently Asked Questions
Who is James Mulay?
James Mulay is a corporate insider at CG Oncology, Inc. (CGON). Mulay has reported 11 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has James Mulay submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has James Mulay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($6.28M) across all tracked filings.
Where can I see all of James Mulay's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live James Mulay profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.